X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (79) 79
index medicus (64) 64
female (43) 43
male (42) 42
aged (35) 35
middle aged (32) 32
aspirin (28) 28
hematology (27) 27
risk factors (25) 25
coronary artery disease (22) 22
peripheral vascular disease (19) 19
platelet aggregation inhibitors - therapeutic use (19) 19
aspirin - therapeutic use (18) 18
cardiology (18) 18
platelet aggregation (18) 18
risk (18) 18
anticoagulants (17) 17
coronary artery disease - drug therapy (17) 17
coronary artery disease - blood (15) 15
administration, oral (14) 14
cardiac & cardiovascular systems (14) 14
care and treatment (14) 14
medicine (14) 14
blood platelets - metabolism (13) 13
cardiovascular diseases (13) 13
patients (13) 13
platelet function tests (13) 13
treatment outcome (13) 13
adult (12) 12
blood platelets - drug effects (12) 12
cardiovascular disease (12) 12
myocardial infarction (12) 12
platelet aggregation - drug effects (12) 12
acute myocardial-infarction (11) 11
clopidogrel (11) 11
coronary heart disease (11) 11
journal article (11) 11
stroke (11) 11
thrombosis (11) 11
anticoagulants - administration & dosage (10) 10
antiplatelet therapy (10) 10
low-dose aspirin (10) 10
pharmacology & pharmacy (10) 10
aged, 80 and over (9) 9
anticoagulants - adverse effects (9) 9
blood platelets - pathology (9) 9
denmark (9) 9
hemorrhage - chemically induced (9) 9
inflammation (9) 9
multidisciplinary sciences (9) 9
prevention (9) 9
science (9) 9
studies (9) 9
time factors (9) 9
acute coronary syndromes (8) 8
aspirin - pharmacology (8) 8
blood platelets (8) 8
coronary vessels (8) 8
coronary-artery-disease (8) 8
drug resistance (8) 8
heart attacks (8) 8
heart diseases (8) 8
metaanalysis (8) 8
myocardial-infarction (8) 8
research article (8) 8
resistance (8) 8
venous thromboembolism (8) 8
warfarin (8) 8
anticoagulants - therapeutic use (7) 7
arachidonic acid (7) 7
atrial fibrillation - drug therapy (7) 7
c-reactive protein (7) 7
cohort studies (7) 7
coronary artery (7) 7
coronary artery disease - complications (7) 7
coronary artery disease - pathology (7) 7
cross-sectional studies (7) 7
drug interactions (7) 7
emergency medicine (7) 7
heart-disease (7) 7
platelet aggregation inhibitors - adverse effects (7) 7
platelets (7) 7
registries (7) 7
thromboembolism (7) 7
ticlopidine - analogs & derivatives (7) 7
usage (7) 7
abridged index medicus (6) 6
activation (6) 6
agglomeration (6) 6
aspirin - adverse effects (6) 6
aspirin resistance (6) 6
bleeding (6) 6
cardiac patients (6) 6
collagen (6) 6
dabigatran (6) 6
diabetes (6) 6
diagnosis (6) 6
medical research (6) 6
medicine, experimental (6) 6
mortality (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Heart, ISSN 1355-6037, 05/2019, Volume 105, Issue 10, pp. 742 - 748
This review provides a comprehensive overview of the available data on antithrombotic therapy after transcatheter aortic valve implantation (TAVI). In the... 
CARDIAC & CARDIOVASCULAR SYSTEMS | ORAL ANTICOAGULANT | STENOSIS | DUAL-ANTIPLATELET THERAPY | PREDICTORS | REPLACEMENT INCIDENCE | RISK | SUBCLINICAL LEAFLET THROMBOSIS | ATRIAL-FIBRILLATION PATIENTS | CORONARY-ARTERY-DISEASE | CLINICAL-OUTCOMES | Heart | Anticoagulants | Cardiac arrhythmia | Stroke | Aspirin | Clinical trials | Acute coronary syndromes | Cardiology | Thrombosis
Journal Article
Stroke, ISSN 0039-2499, 2018, Volume 49, Issue 11, pp. 2568 - 2576
Background and Purpose- Recent studies indicate a possible beneficial effect on neuroregeneration and vascular protection of selective serotonin reuptake... 
drug effects | serotonin | citalopram | stroke | myocardial infarction
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 15805 - 9
We compared the effectiveness and safety of direct oral anticoagulants (DOAC) vs patient self-managed warfarin therapy (PSM) in patients with atrial... 
STROKE | SYSTEM | METAANALYSIS | DABIGATRAN | WARFARIN | MULTIDISCIPLINARY SCIENCES | UPDATE | INTERNATIONAL NORMALIZED RATIO | TRENDS | Anticoagulants | Cardiac arrhythmia | Stroke | Warfarin | Fibrillation | Mortality | Safety | Patients | Bleeding | Embolism
Journal Article
Journal Article
Seminars in Thrombosis and Hemostasis, ISSN 0094-6176, 07/2019, Volume 45, Issue 5, pp. 478 - 489
Abstract Primary prevention of cardiovascular events with aspirin remains controversial, as the risk of bleeding might outweigh the benefits. Recently, new... 
Review Article | cardiovascular events | myocardial infarction | RANDOMIZED-TRIAL | RISK | COLLABORATIVE METAANALYSIS | VASCULAR-DISEASE | DIABETES-MELLITUS | LOW-DOSE ASPIRIN | safety | primary prevention | DOUBLE-BLIND | aspirin | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | diabetes | THROMBOSIS PREVENTION
Journal Article
Seminars in Thrombosis and Hemostasis, ISSN 0094-6176, 04/2018, Volume 44, Issue 3, pp. 249 - 260
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 09/2016, Volume 116, Issue 3, pp. 524 - 529
Patient-self-management (PSM) of oral anticoagulant therapy (OAT) with vitamin K antagonists for venous thromboembolism (VTE) has demonstrated efficacy in... 
Pulmonary embolism | Self-management | Deep-vein thrombosis | Anticoagulation treatment | METAANALYSIS | PERIPHERAL VASCULAR DISEASE | anticoagulation treatment | pulmonary embolism | HEMATOLOGY | self-management
Journal Article